Loewenbaum Group Amends CollPlant Biotechnologies Stake

TL;DR

**Loewenbaum group updated their CollPlant stake, watch for ownership shifts.**

AI Summary

Lillian S. Loewenbaum and related entities, including various trusts and partnerships, filed an amended Schedule 13G/A on January 25, 2024, for their holdings in CollPlant Biotechnologies Ltd. This filing updates their ownership stake as of December 31, 2023. While the specific percentage change isn't detailed in the provided text, an amendment typically signifies a material change in ownership, which could impact the stock's perceived stability or investor confidence for current or potential shareholders.

Why It Matters

Significant ownership changes by large investors can signal shifts in confidence or strategy, potentially influencing market perception and the stock's future performance.

Risk Assessment

Risk Level: low — This filing is a routine update of a passive investment, not indicating any immediate high-risk event.

Analyst Insight

Investors should monitor future 13G/A filings from the Loewenbaum group for any significant changes in their ownership percentage, as a substantial increase or decrease could signal a shift in their long-term outlook on CollPlant Biotechnologies Ltd.

Key Numbers

• NIS 1.5 — par value per Ordinary Share (defines the nominal value of CollPlant's shares)
• 1 — ratio of Ordinary Share per ADS (explains how American Depositary Shares relate to underlying ordinary shares)
• 19516R107 — CUSIP Number (unique identifier for CollPlant's securities)
• 20240125 — filing date (date the SC 13G/A was filed with the SEC)
• 20231231 — date of event (date as of which the ownership information is reported)

Key Players & Entities

• Lillian S. Loewenbaum (person) — filer and beneficiary of trusts
• CollPlant Biotechnologies Ltd. (company) — subject company of the filing
• George Walter Loewenbaum (person) — group member
• Elizabeth S. Loewenbaum (person) — group member
• Lillian S. Loewenbaum Grantor Retained Annuity Trust I (company) — group member and reporting entity

Forward-Looking Statements

• The Loewenbaum group will maintain a significant, passive stake in CollPlant Biotechnologies Ltd. (Loewenbaum Group) — high confidence, target: Next 12 months
• CollPlant Biotechnologies Ltd. will continue to be listed on a major exchange, with its ADSs representing ordinary shares. (CollPlant Biotechnologies Ltd.) — high confidence, target: Next 24 months

FAQ

Filing Documents

• tm244103-1_sc13ga.htm (SC 13G/A) — 154KB
• 0001104659-24-006638.txt ( ) — 156KB

(a)

Item 1(a). Name of Issuer: CollPlant Biotechnologies Ltd. (the “ Issuer ”)

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 4 Oppenheimer St, Weizmann Science Park Rehovot 7670104, Israel

(a). Name of Person(s) Filing

Item 2(a). Name of Person(s) Filing: This statement is filed by the individuals and entities listed below, all of whom together are referred to herein as the “ Reporting Persons ”. (i) George Walter Loewenbaum, an individual (ii) Lillian S. Loewenbaum, an individual (iii) Elizabeth Loewenbaum, an individual (iv) Lil l ian S. Loewenbaum Grantor Retained Annuity Trust I, a Texas trust, (v) Lil l ian S. Loewenbaum Grantor Retained Annuity Trust V, a Texas trust, (vi) Lil l ian S. Loewenbaum Grantor Retained Annuity Trust VI, a Texas trust, (vii) The Loewenbaum 1992 Trust, a Texas trust, and (viii) The Waterproof Partnership, Ltd., a Texas partnership.

(b). Address of Principal Business Office or, if none, Residence

Item 2(b). Address of Principal Business Office or, if none, Residence: The address of the principal business office of each Reporting Person is 1000 Westbank Dr, Ste #2A, Austin, TX 78746.

(c). Citizenship

Item 2(c). Citizenship: See Item 4 of each cover page.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: See the cover page of this filing.

(e). CUSIP Number

Item 2(e). CUSIP Number: 19516R107. Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. -10- CUSIP No. 19516R107 Page 11 of 16

Ownership

Item 4. Ownership. (a) Amount beneficially owned: See Item 9 of each cover page. (b) Percent of class: See Item 11 of each cover page. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: See Item 5 of each cover page. (ii) Shared power to vote or to direct the vote: See Item 6 of each cover page. (iii) Sole power to dispose or to direct the disposition of: See Item 7 of each cover page. (iv) Shared power to dispose or to direct the disposition of: See Item 8 of each cover page. Item 5. If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. -11- CUSIP No. 19516R107 Page 12 of 16

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certification

Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. -12- CUSIP No. 19516R107 Page 13 of 16

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: January 25, 2024 Name: /s/ George Walter Loewenbaum Dated: January 25, 2024 Name: /s/ Lillian S. Loewenbaum Dated: January 25, 2024 Name: /s/ Elizabeth Loewenbaum Dated: January 25, 2024 Lillian S. Loewenbaum Grantor Retained Annuity Trust I By: /s/ George Walter Loewenbaum Name: George Walter Loewenbaum Title: Trustee Dated: January 25, 2024 Lillian S. Loewenbaum Grantor Retained Annuity Trust V By: /s/ George Walter Loewenbaum Name: George Walter Loewenbaum Title: Trustee Dated: January 25, 2024 Lillian S. Loewenbaum Grantor Retained Annuity Trust VI By: /s/ George Walter Loewenbaum Name: George Walter Loewenbaum Title: Trustee Dated: January 25, 2024 The Waterproof Partnership, Ltd. By: /s/ George Walter Loewenbaum Name: George Walter Loewenbaum Title: General Partner By: /s/ Lillian S. Loewenbaum Name: Lillian S. Loewenbaum Title: General Partner Dated: January 25, 2024 The Loewenbaum 1992 Trust By: /s/ George Walter Loewenbaum Name: George Walter Loewenbaum Title: Trustee By: /s/ Lillian S. Loewenbaum Name: Lillian S. Loewenbaum Title: Trustee -13- CUSIP No. 19516R107 Page 14 of 16 EXHIBIT INDEX Exhibit Exhibit A: Joint Filing Agreement. -14- CUSIP No. 19516R107 Page 15 of 16 EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Ordinary Shares, par value NIS 1.5 per share (including Ordinary Shares represented by American Depositary Shares (ADSs) at a ratio of one Ordinary Share per ADS, of CollPlant Biotechnologies Ltd., and further ag

View Full Filing

View this SC 13G/A filing on SEC EDGAR